Evidence map›Paper›PMID 34416067›Full record

ReviewChembiochem : a European journal of chemical biology2022

Non-canonical Amino Acid Substrates of E. coli Aminoacyl-tRNA Synthetases.

Matthew C T Hartman

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Tyrosinase-Catalyzed Peptide Macrocyclization for mRNA Display.Journal of the American Chemical Society · 2023
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Matthew C T HartmanDepartment of Chemistry and Massey Cancer Center, Virginia Commonwealth University, 1001 W Main St., Richmond, VA 23220, USA.
Virginia Commonwealth University · US

Funding

Genetic code expansion for the construction of beyond rule-of-5 compliant macrocyclic peptide librariesR01GM143396 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI HARTMAN, MATTHEW C · 2021 to 2024
$1.2M
Genetic code expansion to enable the development of short, diverse peptide librariesR03CA259876 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HARTMAN, MATTHEW C · 2021 to 2022
$150k
Enabling a new route for the creation of short, diverse peptide libraries through breaking the degeneracy of the genetic codeR03CA216116 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HARTMAN, MATTHEW C · 2017 to 2018
$146k
NCI NIH HHS R03 CA216116NCI NIH HHS R03 CA259876NIGMS NIH HHS R01 GM143396NIH HHS R03CA259876NSF 190482
6 · The paper itself

Abstract

In this comprehensive review, I focus on the twenty E. coli aminoacyl-tRNA synthetases and their ability to charge non-canonical amino acids (ncAAs) onto tRNAs. The promiscuity of these enzymes has been harnessed for diverse applications including understanding and engineering of protein function, creation of organisms with an expanded genetic code, and the synthesis of diverse peptide libraries for drug discovery. The review catalogues the structures of all known ncAA substrates for each of the 20 E. coli aminoacyl-tRNA synthetases, including ncAA substrates for engineered versions of these enzymes. Drawing from the structures in the list, I highlight trends and novel opportunities for further exploitation of these ncAAs in the engineering of protein function, synthetic biology, and in drug discovery.

Indexed as

Amino AcidsAmino Acyl-tRNA SynthetasesEscherichia coliProtein EngineeringSynthetic BiologyAmino AcidsAmino Acyl-tRNA Synthetasesaminoacyl-tRNA synthetasesnon-canonical amino acidsprotein engineeringsubstrate specificitytranslation

Identifiers

PMID34416067
PMCPMC9651912
OpenAlexW3195294009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.